Elevated expression of CEP63 was also correlated with poor DFS of BC patients in TCGA Bladder Cancer (BLCA) data set (Supplementary Figure 4), which indicated the prognostic value of CEP63 on RNA levels. The gene discussed is CEP63; the disease is breast cancer.